Sarepta Therapeutics Inc Q2 2020 Earnings Call Summary - Thomson StreetEvents

Sarepta Therapeutics Inc Q2 2020 Earnings Call Summary

Sarepta Therapeutics Inc Q2 2020 Earnings Call Summary - Thomson StreetEvents
Sarepta Therapeutics Inc Q2 2020 Earnings Call Summary
Published Aug 05, 2020
21 pages (13918 words) — Published Aug 05, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of SRPT.OQ earnings conference call or presentation 5-Aug-20 8:30pm GMT

  
Brief Excerpt:

...A. Highlights: On 03/13/20, all but a small contingent of Co.'s workforce transitioned to virtual work environment. 1. Notwithstanding this unusual approach, Co. is not merely remaining productive, but has become even more efficient and effective as it advances multi-program multiplatform genetic medicine ambitions. a. 2. Has continued to serve patient community with approved therapies. Already achieved or remain on track for many planned 2020 milestones. a. b. Expanded three-pronged approach to building enduring gene therapy engine. c. As Co. has generated additional evidence in 2020, continued to build confidence that unique approach to gene therapy is proving successful and highly differentiated. 3. As Co. continues to serve patient community while endeavoring to keep them safe in this pandemic, 2Q net sales stand at $111.3m. Up 18% increase YoverY. a. 4. As mentioned in last quarterly conference call, withdrew 2020 guidance in light of potential impact of COVID-19 on clinic visits....

  
Report Type:

Brief

Source:
Company:
Sarepta Therapeutics Inc
Ticker
SRPT.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Sarepta Therapeutics Inc Conference Call to Discuss Long-term Functional Data from Gene Therapy Programs to be Presented at WMS25 Transcript – 2020-09-28 – US$ 54.00 – Edited Transcript of SRPT.OQ conference call or presentation 28-Sep-20 12:30pm GMT

Sarepta Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript – 2020-09-16 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 16-Sep-20 6:40pm GMT

Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2020-09-15 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 15-Sep-20 4:30pm GMT

Sarepta Therapeutics Inc at Robert W Baird Global Healthcare Conference Transcript – 2020-09-10 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 10-Sep-20 6:00pm GMT

Sarepta Therapeutics Inc Q2 2020 Earnings Call Transcript – 2020-08-05 – US$ 54.00 – Edited Transcript of SRPT.OQ earnings conference call or presentation 5-Aug-20 8:30pm GMT

Sarepta Therapeutics Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript – 2020-06-24 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 24-Jun-20 4:30pm GMT

Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2020-06-09 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 9-Jun-20 7:00pm GMT

Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Summary – 2020-06-08 – US$ 54.00 – Edited Brief of SRPT.OQ conference call or presentation 8-Jun-20 12:30pm GMT

Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript – 2020-06-08 – US$ 54.00 – Edited Transcript of SRPT.OQ conference call or presentation 8-Jun-20 12:30pm GMT

Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript – 2020-06-04 – US$ 54.00 – Edited Transcript of SRPT.OQ shareholder or annual meeting 4-Jun-20 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Sarepta Therapeutics Inc Q2 2020 Earnings Call Summary" Aug 05, 2020. Alacra Store. May 18, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2020-Sarepta-Therapeutics-Inc-Earnings-Call-B13297900>
  
APA:
Thomson StreetEvents. (2020). Sarepta Therapeutics Inc Q2 2020 Earnings Call Summary Aug 05, 2020. New York, NY: Alacra Store. Retrieved May 18, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2020-Sarepta-Therapeutics-Inc-Earnings-Call-B13297900>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.